Final multivariate analysis results for clinician- and patient-reported 6-month treatment response
| Variable . | OR (95% CI) . | P value . |
|---|---|---|
| Clinician model | ||
| PROM at baseline | 1.3 (1.1-1.6) | .002 |
| PROM change∗ | 1.5 (1.2- 2.0) | .002 |
| NIH skin score change∗ | 0.3 (0.2-0.6) | <.001 |
| Patient model | ||
| Modified HAP (per 10) | 1.5 (1.1-2.1) | .02 |
| SF36 vitality scale change∗ (per 10) | 3.9 (2.0-7.6) | <.001 |
| LSS skin scale (per 10) | 0.6 (0.5-0.8) | <.001 |
| LSS skin scale change∗ (per 10) | 0.4 (0.2-0.6) | <.001 |
| Variable . | OR (95% CI) . | P value . |
|---|---|---|
| Clinician model | ||
| PROM at baseline | 1.3 (1.1-1.6) | .002 |
| PROM change∗ | 1.5 (1.2- 2.0) | .002 |
| NIH skin score change∗ | 0.3 (0.2-0.6) | <.001 |
| Patient model | ||
| Modified HAP (per 10) | 1.5 (1.1-2.1) | .02 |
| SF36 vitality scale change∗ (per 10) | 3.9 (2.0-7.6) | <.001 |
| LSS skin scale (per 10) | 0.6 (0.5-0.8) | <.001 |
| LSS skin scale change∗ (per 10) | 0.4 (0.2-0.6) | <.001 |
CI, confidence interval; OR, odds ratio.
Change from baseline to 6 months